CoChat

The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.

Recent advances in modulation of cardiovascular diseases by the gut microbiota

Open access

Abstract

The gut microbiota has recently gained attention due to its association with cardiovascular health, cancers, gastrointestinal disorders, and non-communicable diseases. One critical question is how the composition of the microbiota contributes to cardiovascular diseases (CVDs). Insightful reviews on the gut microbiota, its metabolites and the mechanisms that underlie its contribution to CVD are limited. Hence, the aim of this review was to describe linkages between the composition of the microbiota and CVD, CVD risk factors such as hypertension, diet, ageing, and sex differences. We have also highlighted potential therapies for improving the composition of the gut microbiota, which may result in better cardiovascular health.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41371-022-00698-6

Cites

86 of 86 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Diseases associated with dysbiosis. Abnormal changes in the composition of the microbiota (dysbiosis) is positively associated with pathogenesis and propagation of heart disease, atherosclerosis, hypertension, obesity, type 2 diabetes mellitus, cancer, and gastrointestinal disorders.
Fig. 1 Diseases associated with dysbiosis. Abnormal changes in the composition of the microbiota (dysbiosis) is positively associated with pathogenesis and propagation of heart disease, atherosclerosis, hypertension, obesity, type 2 diabetes mellitus, cancer, and gastrointestinal disorders.CC BY · PubMed Central
Fig. 2 Microbiota’s contribution to atherosclerosis and CVD. Ammonia (NH3) and ammonium hydroxide (NH4OH) resulting from kidney disease or the action of microbial urease and HIV infection in the gut contributes to microbial translocation and systemic inflammation. Microbes colonize atherosclerotic plaques enhancing progression of various atherosclerotic processes. Dysbiosis contributes to decreased bile formation that results in decreased cholesterol elimination and increased plasma levels of low-density lipoproteins. LEESE Lactobacillus, Esherichia, Enterococcus, Shigella, and Streptococcus, FREBS Faecalibacterium, Roseburia, Eubacterium rectale, Bacteroides fragilis, and Subdoligranulum.
Fig. 2 Microbiota’s contribution to atherosclerosis and CVD. Ammonia (NH3) and ammonium hydroxide (NH4OH) resulting from kidney disease or the action of microbial urease and HIV infection in the gut contributes to microbial translocation and systemic inflammation. Microbes colonize atherosclerotic plaques enhancing progression of various atherosclerotic processes. Dysbiosis contributes to decreased bile formation that results in decreased cholesterol elimination and increased plasma levels of low-density lipoproteins. LEESE Lactobacillus, Esherichia, Enterococcus, Shigella, and Streptococcus, FREBS Faecalibacterium, Roseburia, Eubacterium rectale, Bacteroides fragilis, and Subdoligranulum.CC BY · PubMed Central
Fig. 3 Gut microbiota and high blood pressure. Microbiota metabolites SCFAs modulate distinct GPCRs and thereby affect blood pressure. For example, activation of Gpr43 and 41 results in vasodilation and blood pressure attenuation. In contrast, activation of olfr78 increases SNA and renin secretion resulting in blood pressure elevation. Moreover, high salt depletes lactobacillus spp. causing dysbiosis and activation of inflammatory immune response by releasing IL-17 and other inflammatory signaling molecules consequently causing blood pressure elevation. FMT is strong evidence to show that gut microbiota plays an indispensable role in the contribution of high blood pressure. SCFAs short-chain fatty acids, GPCRs G protein-coupled receptors, SNA sympathetic nerve activity, FMT fecal microbiota transplantation, GF germ free.
Fig. 3 Gut microbiota and high blood pressure. Microbiota metabolites SCFAs modulate distinct GPCRs and thereby affect blood pressure. For example, activation of Gpr43 and 41 results in vasodilation and blood pressure attenuation. In contrast, activation of olfr78 increases SNA and renin secretion resulting in blood pressure elevation. Moreover, high salt depletes lactobacillus spp. causing dysbiosis and activation of inflammatory immune response by releasing IL-17 and other inflammatory signaling molecules consequently causing blood pressure elevation. FMT is strong evidence to show that gut microbiota plays an indispensable role in the contribution of high blood pressure. SCFAs short-chain fatty acids, GPCRs G protein-coupled receptors, SNA sympathetic nerve activity, FMT fecal microbiota transplantation, GF germ free.CC BY · PubMed Central
Fig. 4 TMAO biosynthesis and metabolism. Choline, phosphatidylcholine, and l-carnitine found in fish, red meat and eggs are metabolized into TMA by colonic microbiota. The TMA that enters the systemic circulation is oxidized into TMAO by FMO3 in the liver, which is released back into the circulation, leading to platelet and inflammatory pathway activation. Inflammatory injury in the endothelium, along with increased foam cell formation and platelet activation, contributes to the progression of atherosclerosis and development of atherothrombotic events.
Fig. 4 TMAO biosynthesis and metabolism. Choline, phosphatidylcholine, and l-carnitine found in fish, red meat and eggs are metabolized into TMA by colonic microbiota. The TMA that enters the systemic circulation is oxidized into TMAO by FMO3 in the liver, which is released back into the circulation, leading to platelet and inflammatory pathway activation. Inflammatory injury in the endothelium, along with increased foam cell formation and platelet activation, contributes to the progression of atherosclerosis and development of atherothrombotic events.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 86 references

Cited by

See all 121

Metadata

Authors
Masenga, S. K., Hamooya, B., Hangoma, J., Hayumbu, V., Ertuglu, L. A., Ishimwe, J., Rahman, S., Saleem, M., Laffer, C. L., Elijovich, F., & Kirabo, A.
Affiliations
  • Mulungushi University (ZM)
  • Vanderbilt University Medical Center (US)
Corresponding author
Kirabo, Annet
Venue
Journal of Human Hypertension
Published
2022-04-25
Volume
36
Issue
11
Pages
952-959
ISSN
  • 0950-9240 (ISSN-L)
  • 1476-5527
OpenAlex
W4224935391
Cited by
121
References
86
Citations by year
2026: 22 · 2025: 29 · 2024: 35 · 2023: 27 · 2022: 8
FWCI
2.58
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Human Hypertension (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Health & Human Services | NIH | Fogarty International Center (TW009744, TW009337)
  • U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R03HL155041, R01HL144941)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
Keywords
gut microbiota, cardiovascular disease, microbiota composition, gut microbiota metabolites, hypertension, diet, aging, sex differences, microbiota-targeted therapy, cardiovascular risk factors
MeSH terms
Gastrointestinal Microbiome, Cardiovascular Diseases, Cardiovascular System, Diet, Female, Humans, Hypertension, Male

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Recent advances in modulation of cardiovascular diseases by the gut microbiota. https://app.cochat.ai/papers/10.1038/s41371-022-00698-6
The paper
Masenga, S. K., Hamooya, B., Hangoma, J., Hayumbu, V., Ertuglu, L. A., Ishimwe, J., Rahman, S., Saleem, M., Laffer, C. L., Elijovich, F., & Kirabo, A. (2022). Recent advances in modulation of cardiovascular diseases by the gut microbiota. Journal of Human Hypertension. https://doi.org/10.1038/s41371-022-00698-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.